All regulations
Nonrulemaking
FDA
FDA-2026-N-7232
FDA’s Strategy Document on Facilitating Chemistry, Manufacturing, and Controls Readiness for Products With Accelerated Clinical Development
Documents
1
Comments
0
Key Dates
Comment Period OpensJul 23, 2026
Documents
| Type | Title | Status |
|---|---|---|
Notice |
Keywords
CDER
FDA’s Strategy Document on
Facilitating Chemistry, Manufacturing
and Controls Readiness for Products
With Accelerated Clinical Development
OPEN
Data from Regulations.gov